First Tracks Biotherapeutics (NASDAQ:TRAX) — Stock Price

First Tracks Biotherapeutics (NASDAQ:TRAX) is currently trading at $47.92 USD, up 5.71% today. Over the past 52 weeks, shares have ranged between $15.32 and $47.92. This page tracks First Tracks Biotherapeutics's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of First Tracks Biotherapeutics.

First Tracks Biotherapeutics (TRAX) Stock Price Chart — Daily History & Trading Volume

The chart below tracks First Tracks Biotherapeutics's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.

First Tracks Biotherapeutics Income Statement — Revenue, Profit & Earnings by Year

First Tracks Biotherapeutics's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

First Tracks Biotherapeutics Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes First Tracks Biotherapeutics's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

First Tracks Biotherapeutics Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how First Tracks Biotherapeutics generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

First Tracks Biotherapeutics Earnings History — EPS Actual vs. Analyst Estimates

Track First Tracks Biotherapeutics's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.